We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
Cap. Flow
-$2.07B
Cap. Flow %
-2.5%
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$433M
2
LOW icon
Lowe's Companies
LOW
+$277M
3
ORCL icon
Oracle
ORCL
+$226M
4
PGR icon
Progressive
PGR
+$220M
5
LVS icon
Las Vegas Sands
LVS
+$167M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Healthcare 15.3%
3 Industrials 15.12%
4 Technology 14.91%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
26
Wells Fargo
WFC
$261B
$724M 0.87%
15,064,571
-611,398
-4% -$30.1M
LKQ icon
27
LKQ Corp
LKQ
$6.58B
$699M 0.84%
11,643,899
-752,203
-6% -$42.4M
CVS icon
28
CVS Health
CVS
$137B
$690M 0.83%
6,686,484
+1,895,954
+40% +$175M
SCHW
29
Charles Schwab
SCHW
$177B
$676M 0.81%
8,024,213
-291,294
-4% -$23.6M
AMP icon
30
Ameriprise Financial
AMP
$46.8B
$669M 0.81%
2,218,182
-21,537
-1% -$6.37M
GS icon
31
Goldman Sachs
GS
$313B
$668M 0.8%
1,744,404
-79,779
-4% -$31.6M
HWM icon
32
Howmet Aerospace
HWM
$116B
$656M 0.79%
20,598,448
+234,677
+1% +$7.23M
ICLR icon
33
Icon
ICLR
$12.8B
$654M 0.79%
2,114,899
-40,538
-2% -$11.3M
CCEP icon
34
Coca-Cola Europacific Partners
CCEP
$46.5B
$650M 0.78%
11,625,590
+283,315
+2% +$15.3M
CNP icon
35
CenterPoint Energy
CNP
$29.1B
$650M 0.78%
23,283,652
-518,129
-2% -$13.8M
HBAN icon
36
Huntington Bancshares
HBAN
$35.1B
$645M 0.78%
41,816,672
-1,164,187
-3% -$18.3M
GPN icon
37
Global Payments
GPN
$22.1B
$637M 0.77%
4,705,549
+1,908,708
+68% +$263M
GD icon
38
General Dynamics
GD
$105B
$625M 0.75%
2,998,035
+85,186
+3% +$17.2M
COR icon
39
Cencora
COR
$60.3B
$618M 0.74%
4,654,414
-134,190
-3% -$16.5M
EG icon
40
Everest Group
EG
$15.2B
$616M 0.74%
2,250,498
-51,864
-2% -$14M
MU icon
41
Micron Technology
MU
$1.04T
$604M 0.73%
6,485,956
-756,431
-10% -$59.1M
MCK icon
42
McKesson
MCK
$98.5B
$604M 0.73%
2,431,337
-96,655
-4% -$21.2M
MHK icon
43
Mohawk Industries
MHK
$6.9B
$599M 0.72%
3,286,756
-132,295
-4% -$23.6M
CTSH icon
44
Cognizant
CTSH
$21.5B
$593M 0.71%
6,685,153
+1,405,697
+27% +$113M
AIG icon
45
American International
AIG
$41.9B
$590M 0.71%
10,364,266
-1,059,522
-9% -$60.3M
GEN icon
46
Gen Digital
GEN
$15.6B
$583M 0.7%
22,434,260
+4,748,508
+27% +$120M
KDP icon
47
Keurig Dr Pepper
KDP
$40.4B
$575M 0.69%
+15,605,496
New +$550M
TEL icon
48
TE Connectivity
TEL
$58.8B
$568M 0.68%
3,521,581
-52,769
-1% -$8.16M
NXPI icon
49
NXP Semiconductors
NXPI
$68B
$535M 0.64%
2,347,854
-673,008
-22% -$143M
TXT icon
50
Textron
TXT
$16.6B
$529M 0.64%
6,855,065
-272,630
-4% -$20.2M

Similar funds

Boston Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
  • Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
  • Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
  • Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
  • Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
  • Boston Partners opened 59 new positions and closed 45 in Q4 2021.
  • Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.

Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.